On an annual basis, sales were KRW 4.03 billion in 2023, KRW 3.41 billion in 2024 (down 15.4% year on year) and KRW 5.33 billion in 2025 (up 56.4%), making 2025 the largest year and 2024 the smallest within 2023–2025.
The operating loss was KRW 7.77 billion in 2023 and widened to KRW 10.6 billion in 2024 before narrowing to KRW 8.66 billion in 2025, with operating margins of -192.9%, -311.5% and -162.6% respectively.
The net loss attributable to controlling shareholders shrank each year, from KRW 10.4 billion in 2023 to KRW 9.58 billion in 2024 and KRW 7.93 billion in 2025, and the consolidated net loss including non-controlling interests followed the same path.
Operating cash outflows were KRW -6.23 billion in 2023, KRW -6.65 billion in 2024 and KRW -6.2 billion in 2025, so roughly KRW 6 billion a year left the business through operations.
The debt ratio stayed low at 18.0%, 4.9% and 7.8% over the same years, which places the financial burden in the size of operating losses rather than in borrowings.
Quarterly sales rose from KRW 1.12 billion in the third quarter of 2025 to KRW 1.7 billion in the fourth quarter, up 52.5% sequentially, then fell to KRW 1.27 billion in the first quarter of 2026, down 25.1%.
Sales recovered to KRW 1.51 billion in the second quarter of 2026, up 18.4% sequentially, and reached KRW 1.21 billion in the third quarter, down 20.1% sequentially but up 8.1% year on year.
The operating loss narrowed from KRW 2.46 billion in the first quarter of 2026 to KRW 1.41 billion in the second quarter, then widened again to KRW 2.08 billion in the third quarter.
In the third quarter, the operating loss was smaller than the KRW 2.57 billion of a year earlier, but the net loss attributable to controlling shareholders rose to KRW 2.62 billion from KRW 2.31 billion, so non-operating items need to be read alongside operating results.
The net loss attributable to controlling shareholders totaled KRW 7.9 billion over the last four quarters, and whether the product upgrades and wider recognition cited for 2025 growth held up in quarterly sales remains an open question.
A Korean IR advisory research note had estimated 2025 sales at KRW 6.4 billion and an operating loss of KRW 7.7 billion, while the disclosed figures were KRW 5.33 billion and KRW 8.66 billion.